Abstracts

SUBMISSION OF ABSTRACTS
Communications should concern all aspects of nephrology, the prevention and treatment of renal diseases and associated conditions or the scientific background to the study of the kidney.

GENERAL RULES
All abstracts must be submitted electronically through the WCN 2009 website

All abstracts must be received by January 9, 2009.

Abstracts received after this date cannot be considered by the Paper Selection Committee.

CONFIRMATION
You will automatically receive an e-mail confirming our receipt of your abstract.

NOTIFICATION
The Presenting Author of each abstract accepted for publication will be notified by April 6,
2009. If the Presenting Author is unable to present the abstract, another co-author can take
his/her place. A letter from the Presenting Author about the change is requested and must be
received by the WCN 2009 Congress Office by April 30, 2009.

WITHDRAWAL / CHANGES
Submitted abstracts cannot be withdrawn or changed. No exceptions will be made.

ORIGINAL ABSTRACTS
Submitted abstracts must describe unpublished work which is not already in press and which is
not awaiting possible acceptance by any other society that publishes its proceedings.

HOW TO SUBMIT ABSTRACTS
Only submission through the WCN 2009 website is possible. Abstracts sent by post or email will
not be accepted.
You can send your abstracts from October 2008. Please click on the button abstract submission.
All authors of correctly written and successfully submitted abstracts will receive confirmation by
e-mail. Should you experience any unforeseen problems with the electronic submission, please
contact:
Marathon International
Phone: 31-229-211980
Fax: 31-229-211241
E-mail: support@marathonmultimedia.com

Do not mail or fax your abstract to the WCN 2009 Congress Office.




LATE BREAKING CLINICAL TRIALS
The results of late breaking clinical trials of extraordinary importance that have not yet been presented elsewhere can be submitted by email (program@wcn2009.org) until April 3, 2009 if the data analysis cannot be performed prior to the regular abstract deadline. Studies submitted through this “late breaking trial” track, which do not meet these criteria, will not be considered for presentation.